Zobrazeno 1 - 10
of 976
pro vyhledávání: '"Dunne, Mw"'
Autor:
Dunne MW; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA., Aronin SI; Iterum Therapeutics, Old Saybrook, CT, USA. Electronic address: saronin@iterumtx.com., Das AF; Das Statistical Consulting, Guerneville, CA, USA., Akinapelli K; Takeda, Cambridge, MA, USA., Breen JD; Old Saybrook, CT, USA., Zelasky MT; Johnson & Johnson, Cambridge, MA, USA., Puttagunta S; Boston, MA, USA.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Nov 02. Date of Electronic Publication: 2024 Nov 02.
Autor:
Hsia J; Colorado Prevention Center and Department of Medicine, University of Colorado, Aurora, Colorado, United States., Spyropoulos AC; Feinstein Institutes for Medical Research and Department of Medicine, Northwell Health, New York, New York, United States., Piazza G; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States., Weng S; Janssen Research and Development, Statistical Decision Sciences, Cardiovascular and Metabolism, High Wycombe, United Kingdom., Dunne MW; Bill and Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States., Lipardi C; Janssen Research and Development, Clinical Development, Raritan, New Jersey, United States., Barnathan ES; Janssen Research and Development, Clinical Development, Raritan, New Jersey, United States., Bonaca MP; Colorado Prevention Center and Department of Medicine, University of Colorado, Aurora, Colorado, United States.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2024 Jul; Vol. 124 (7), pp. 649-655. Date of Electronic Publication: 2023 Nov 23.
Autor:
Gonzalez PL; Infectious Disease Medical Affairs and Internal Medicine, AbbVie, Madison, NJ, USA. papitin@yahoo.com.; Becton-Dickinson, 1 Becton Dr, Franklin Lakes, NJ, 07417-1880, USA. papitin@yahoo.com., Rappo U; Clinical Development, Infectious Diseases, AbbVie, Madison, NJ, USA.; BiomX Inc., Branford, CT, USA., Akinapelli K; Medical Affairs Infectious Diseases, AbbVie, Madison, NJ, USA.; Iterum Therapeutics, Old Saybrook, CT, USA., McGregor JS; Medical Affairs Infectious Diseases, AbbVie, Madison, NJ, USA., Puttagunta S; Infectious Disease Medical Affairs and Internal Medicine, AbbVie, Madison, NJ, USA.; BiomX Inc., Branford, CT, USA., Dunne MW; Infectious Disease Medical Affairs and Internal Medicine, AbbVie, Madison, NJ, USA.; Iterum Therapeutics, Old Saybrook, CT, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2022 Feb; Vol. 11 (1), pp. 423-434. Date of Electronic Publication: 2021 Dec 14.
Autor:
Dunne MW; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Aronin SI; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Das AF; Das Statistical Consulting, Guerneville, California, USA., Gupta J; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Akinapelli K; Takeda Pharmaceuticals, Cambridge, Massachusetts, USA., Zelasky MT; Johnson & Johnson, Cambridge, Massachusetts, USA., Puttagunta S; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Boucher HW; Tufts Medicine and Tufts University School of Medicine, Boston, Massachusetts, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 05; Vol. 77 (1), pp. 159-161.
Autor:
Dunne MW; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Aronin SI; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Das AF; Das Statistical Consulting, Guerneville, California, USA., Akinapelli K; Takeda Pharmaceuticals, Cambridge, MA, USA., Breen J; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Zelasky MT; Johnson & Johnson, Cambridge, Massachusetts, USA., Puttagunta S; Iterum Therapeutics, Old Saybrook, Connecticut, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jan 06; Vol. 76 (1), pp. 78-88.
Autor:
Dunne MW; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Aronin SI; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Das AF; Das Statistical Consulting, Guerneville, California, USA., Akinapelli K; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Zelasky MT; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Puttagunta S; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Boucher HW; Tufts Medicine and Tufts University School of Medicine, Boston Massachusetts, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jan 06; Vol. 76 (1), pp. 66-77.
Autor:
Ananworanich J; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Mogg R; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Dunne MW; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Bassyouni M; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., David CV; Department of Allergy, Asthma and Clinical Research, Science 37, Los Angeles, California, USA., Gonzalez E; Department of Medical Affairs, South Texas Allergy & Asthma Medical Professionals, San Antonio, Texas, USA., Rogalski-Salter T; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Shih H; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Silverman J; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Medema J; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Heaton P; Department of Clinical Development, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Aug 24; Vol. 75 (1), pp. e473-e481.
Autor:
Aronin SI; Iterum Therapeutics, Old Saybrook, CT, USA. Electronic address: saronin@iterumtx.com., Dunne MW; Iterum Therapeutics, Old Saybrook, CT, USA; Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA., Yu KC; Becton, Dickinson and Company, Franklin Lakes, NJ, USA., Watts JA; Becton, Dickinson and Company, Franklin Lakes, NJ, USA., Gupta V; Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
Publikováno v:
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2022 Aug; Vol. 103 (4), pp. 115717. Date of Electronic Publication: 2022 Apr 29.
Autor:
Aronin SI; Iterum Therapeutics, Old Saybrook, Connecticut, United States., Gupta V; Becton, Dickinson and Company, Franklin Lakes, New Jersey, United States., Dunne MW; Iterum Therapeutics, Old Saybrook, Connecticut, United States; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States., Watts JA; Becton, Dickinson and Company, Franklin Lakes, New Jersey, United States., Yu KC; Becton, Dickinson and Company, Franklin Lakes, New Jersey, United States. Electronic address: Kalvin.Yu@bd.com.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 Jun; Vol. 119, pp. 142-145. Date of Electronic Publication: 2022 Mar 30.
Autor:
Dunne MW; Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Aronin SI; Iterum Therapeutics, Old Saybrook, Connecticut, USA., Yu KC; Becton, Dickinson and Company, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA., Watts JA; Becton, Dickinson and Company, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA., Gupta V; Becton, Dickinson and Company, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA. vikas.gupta@bd.com.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2022 Feb 28; Vol. 22 (1), pp. 194. Date of Electronic Publication: 2022 Feb 28.